Clinical studies recruiting near Fuenlabrada

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Phase 2 · SOLTI Breast Cancer Research Group · NCT07371585 A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · Hospital Universitario de Fuenlabrada /ID# 255093 · AbbVie · NCT04928846 Clinical Trial on HIPEC With Mitomycin C in Colon Cancer Peritoneal Metastases (GECOP-MMC)
Phase 4 · HOSPITAL UNIVERSITARIO DE FUENLABRADA (Coordinating Centre) · Hospital Universitario de Fuenlabrada · NCT05250648 Observation of Clinical Routine Care for Patients With BIOTRONIK Implantable Cardiac Monitors (ICMs)
Phase N/A · Hospital de Fuenlabrada · Biotronik SE & Co. KG · NCT04075084 Thoracic Tumours Register
Phase N/A · H. Fuenlabrada · Spanish Lung Cancer Group · NCT02941458 Short Versus Long-term Androgen Deprivation Therapy With Salvage Radiotherapy in Prostate Cancer. URONCOR 0624
Phase 3 · Hospital Universitario de Fuenlabrada · Instituto de Investigación en Oncología Radioterápica - Fund · NCT05781217 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Treatment of Breakpoint Cluster Region-Abelson (BCR-ABL) Negative ALL in Adults
NA · H. Fuenlabrada · PETHEMA Foundation · NCT04179929 Registry of Thrombosis & NEoplasia of "Sociedad Española de Oncología Médica"
Phase N/A · Hospital de Fuenlabrada · Fundación Sociedad Española de Oncologia Médica · NCT03855592 OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Phase 3 · Clinical Trial Site · Olema Pharmaceuticals, Inc. · NCT06016738 External Validation of the CLOVER Score for Detecting Occult Cancer in Venous Thromboembolism Patients
Phase N/A · Infanta Leonor University Hospital · NCT07310693 CRS Questionnaire Validation Project
Phase N/A · The European Forum for Research and Education in Allergy and · NCT06970977 High Definition Medicine for Solid Tumors Oncology
Phase N/A · Hospital Universitario de Fuenlabrada · Centro Nacional de Investigaciones Oncologicas CARLOS III · NCT06590506 Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Phase 2 · Hospital Universitario de Fuenlabrada · Abivax S.A. · NCT06456593 LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Phase 2 · Hospital Universitario de Fuenlabrada · Eli Lilly and Company · NCT07186101 Multicenter Study Protocol: Research on Evaluation and Detection of Surgical Wound Complications with AI-based Recogniti
Phase 2/Phase 3 · Universitat de les Illes Balears · NCT06771726 Safety of IBD Drugs During Pregnancy and Breastfeeding: Mothers and Babies' Outcomes (DUMBO Registry)
Phase N/A · Hospital Universitario de Fuenlabrada · Grupo Espanol de Trabajo en Enfermedad de Crohn y Colitis Ul · NCT03894228 Computerized Registry of Patients With Venous Thromboembolism (RIETE)
Phase N/A · Hospital Universitario de Fuenlabrada · Manuel Monreal · NCT02832245 Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Neg
Phase 3 · Hospital Universitario de Fuenlabrada · Gilead Sciences · NCT05633654 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Sever
Phase 3 · Hospital Universitario de Fuenlabrada /ID# 257334 · AbbVie · NCT06012240 Effects of Physical Exercise Combined With Transcranial Direct Current Stimulation in Parkinson's Disease
NA · Center of Sport Research · Universidad Rey Juan Carlos · NCT07524400 A Prospective Registry Study in Patients With Unresectable Locally Advanced or Metastatic Breast Cancer (MBC)
Phase N/A · Hospital Universitario de Fuenlabrada · Spanish Breast Cancer Research Group · NCT02819882 NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide
Phase 3 · PETHEMA Foundation · NCT05558319 Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subje
Phase 3 · Hospital Universitario de Fuenlabrada · Greenwich LifeSciences, Inc. · NCT05232916 OSPREY is a Post-market, Global, Multicentre, Observational, Prospective Registry.
Phase N/A · OncoSil Medical Limited · NCT04493632 Chemotherapy De-escalation in HR +, HER2-, Intermediate-risk Early Breast Cancer Treated With Adjuvant Ribociclib
Phase 3 · Hospital Universitario de Fuenlabrada · UNICANCER · NCT07237256 Trajectories of Anxiety and Depression in Cancer Patients, Risk and Predictive Factors and Supportive Care; Prognostic A
Phase N/A · Hospital Universitario Fuenlabrada · Fundación Sociedad Española de Oncologia Médica · NCT07168096 Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute
Phase 1/Phase 2 · Hospital Universitario de Fuenlabrada · PEACHES BIOTECH · NCT06684379 Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies
Phase N/A · Spanish Breast Cancer Research Group · NCT03390894 Inhaled Sedation in Critically Ill Patients
Phase 4 · Instituto de Investigación Hospital Universitario La Paz · NCT07000526

Look up another city

Look up another condition